Description

1,3-Dihydro-7-Chloro-1-(2-Ethoxyethyl)-5-Phenyl-2H-1,4-Benzodiazepin-2-One CAS NO 6515-69-1 is a high-purity benzodiazepine derivative, a crucial pharmaceutical intermediate in the synthesis of active pharmaceutical ingredients (APIs). Its value lies in providing a reliable and consistent building block for complex drug molecules, ensuring downstream process stability and final product quality. This compound is essential for pharmaceutical R&D laboratories and manufacturers developing and producing specialized therapeutic agents.

Application

• Pharmaceutical Intermediate: Primary use as a key synthetic precursor in the manufacture of benzodiazepine-class active pharmaceutical ingredients (APIs).
• Research & Development: Serves as a critical starting material or intermediate in medicinal chemistry for the discovery and development of new therapeutic compounds.
• Reference Standard: Used as a high-purity analytical standard in quality control laboratories for method development, validation, and impurity profiling.
• Chemical Synthesis: Employed in organic synthesis for constructing complex heterocyclic structures in academic and industrial research settings.

Basic Information

Product Name	1,3-Dihydro-7-Chloro-1-(2-Ethoxyethyl)-5-Phenyl-2H-1,4-Benzodiazepin-2-One
CAS No.	6515-69-1
Molecular Formula	C19H19ClN2O2
Molecular Weight	342.82 g/mol
Synonyms	7-Chloro-1-(2-ethoxyethyl)-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; 1-(2-Ethoxyethyl)-7-chloro-5-phenyl-1,3-dihydro-2H-1,4-benzodiazepin-2-one; Ethyl Loflazepate Impurity; Ethyl Loflazepate Related Compound; Ethyl Loflazepate Intermediate; Meilax Intermediate; Victan Intermediate; Benzodiazepine Derivative 6515-69-1
EINECS	Contact for details

Quality Control

Our 1,3-Dihydro-7-Chloro-1-(2-Ethoxyethyl)-5-Phenyl-2H-1,4-Benzodiazepin-2-One is manufactured under strict quality management systems. Each batch undergoes rigorous analytical testing, including HPLC, NMR, and IR spectroscopy, to ensure identity, purity, and consistency. We provide comprehensive Certificates of Analysis (COA) with each shipment, detailing all specification results. Our quality commitment aligns with cGMP principles for pharmaceutical intermediates, ensuring reliability for critical applications.

Storage

Preserve in a tightly closed container, protected from light. Store in a cool, dry, and well-ventilated area at controlled room temperature (15-25°C). Keep the container tightly sealed to protect from moisture. Store away from incompatible materials.

Specification

Item	Specification
Appearance	White to off-white crystalline powder
Identification (IR)	Conforms to structure
Identification (HPLC)	Retention time matches reference standard
Assay (HPLC)	≥98.0%
Related Substances (HPLC)	Total impurities ≤2.0%
Single Maximum Impurity	≤0.5%
Loss on Drying	≤0.5%
Residue on Ignition	≤0.1%

Note: Specifications can be tailored. Please contact us for the detailed technical data sheet of a specific grade.